Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with long COVID and those who experienced side effects from mRNA vaccines are seeking Novavax’s protein-based offering.
New flu and COVID vaccines are available for everyone, and RSV vaccines for people 60 and older.
Many nursing homes will not begin inoculations until well into October or even November.
The protein-based vaccine works in a different way than the mRNA vaccines from Moderna and Pfizer-BioNTech.
The technology, developed by Katalin Karikó and Drew Weissman, also holds promise for HIV vaccines and cancer treatment.
A boost in protection is needed to offset the persistent disparities in the toll of COVID between racial and ethnic groups.
The vaccines tend to prevent infection for only a few months, but they offer longer protection against hospitalization and death.
Updated coronavirus vaccine is recommended for all adults and children ages 6 months and older.
People at lower risk may not need an updated booster, but without a CDC recommendation, insurance companies wouldn’t have to cover it.
People ages 6 months and older are eligible for new Moderna and Pfizer-BioNTech boosters targeting XBB.1.5 omicron variant.
Who should get flu, COVID and RSV vaccines—and when?
COVID mortality declined overall during the omicron wave but less so for people with HIV.
Antibodies crossed the placenta, likely conferring some protection for newborns immediately after birth.
The program, launching this fall, will help uninsured people and those whose insurance does not cover free vaccines.
The share of kindergartners receiving the usual round of required vaccines dropped in the 2021-2022 school year.
A booster targeting Omicron SARS-CoV-2 variant produced a broader immune response than one targeting variants similar to original strain.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.